Invention Grant
- Patent Title: Immunoglobulin chimeric monomer-dimer hybrids
-
Application No.: US15491742Application Date: 2017-04-19
-
Publication No.: US09725496B1Publication Date: 2017-08-08
- Inventor: Robert T. Peters , Adam R. Mezo , Daniel S. Rivera , Alan J. Bitonti , Susan C. Low
- Applicant: Bioverativ Therapeutics Inc.
- Applicant Address: US MA Waltham
- Assignee: Bioverative Therapeutics Inc.
- Current Assignee: Bioverative Therapeutics Inc.
- Current Assignee Address: US MA Waltham
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Main IPC: C07K14/715
- IPC: C07K14/715 ; C07K14/72 ; C07K14/475 ; C07K14/755 ; C07K14/705 ; C07K14/61 ; C07K14/56 ; C07K14/505 ; C07K14/59 ; C07K14/565 ; A61K47/48 ; C12N9/64 ; C12N9/96 ; A61K38/00

Abstract:
The invention relates to a chimeric monomer-dimer hybrid protein wherein the protein comprises a first and a second polypeptide chain, the first polypeptide chain comprising at least a portion of an immunoglobulin constant region and a biologically active molecule, and the second polypeptide chain comprising at least a portion of an immunoglobulin constant region without the biologically active molecule of the first chain. The invention also relates to methods of using and methods of making the chimeric monomer-dimer hybrid protein of the invention.
Public/Granted literature
- US20170226189A1 IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS Public/Granted day:2017-08-10
Information query